We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

156 hedge funds and large institutions have $703M invested in Aerie Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more capital invested

Capital invested by funds: $354M → $703M (+$350M)

58% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 33

34% more call options, than puts

Call options by funds: $610K | Put options by funds: $454K

14% more funds holding

Funds holding: 137 → 156 (+19)

4% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 45

Holders
156
Holders Change
+19
Holders Change %
+13.87%
% of All Funds
2.69%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
52
Increased
47
Reduced
45
Closed
33
Calls
$610K
Puts
$454K
Net Calls
+$156K
Net Calls Change
+$65K

Top Buyers

Rank Fund Capital Flow
1
WIC
Water Island Capital
New York
+$24.2M
2
NAM
Nexpoint Asset Management
Texas
+$18.4M
3
AA
AQR Arbitrage
Connecticut
+$12.5M
4
AAM
Alpine Associates Management
Florida
+$12M
5
Goldman Sachs
Goldman Sachs
New York
+$9.16M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$17.7M
2
Ameriprise
Ameriprise
Minnesota
-$15.1M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$11.4M
4
RCMNY
Rubric Capital Management (New York)
New York
-$9.24M
5
CWG
C WorldWide Group
Denmark
-$8.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
76
ExodusPoint Capital Management
New York
$720K +$553K +47,605 New
Two Sigma Investments
77
Two Sigma Investments
New York
$719K +$206K +17,700 +59%
Nomura Holdings
78
Nomura Holdings
Japan
$709K +$545K +46,893 New
JF
79
Jump Financial
Illinois
$694K +$533K +45,846 New
Stifel Financial
80
Stifel Financial
Missouri
$691K -$1.67M -143,361 -76%
GI
81
GAMCO Investors
Connecticut
$682K +$524K +45,050 New
Voloridge Investment Management
82
Voloridge Investment Management
Florida
$679K -$917K -78,920 -64%
State of Wisconsin Investment Board
83
State of Wisconsin Investment Board
Wisconsin
$674K +$396K +34,059 +324%
BFM
84
Boothbay Fund Management
New York
$614K +$472K +40,600 New
MAM
85
Martingale Asset Management
Massachusetts
$580K +$445K +38,299 New
Natixis Advisors
86
Natixis Advisors
Massachusetts
$565K +$2.13K +183 +0.5%
SMC
87
S. Muoio & Co
New York
$555K +$426K +36,655 New
Allspring Global Investments
88
Allspring Global Investments
North Carolina
$543K -$4.63K -398 -1%
Mirae Asset Global Investments
89
Mirae Asset Global Investments
South Korea
$530K +$22.8K +1,965 +6%
CSS
90
Cubist Systematic Strategies
Connecticut
$489K +$61.8K +5,313 +20%
PCM
91
PenderFund Capital Management
British Columbia, Canada
$480K +$267K +22,950 New
AQR Capital Management
92
AQR Capital Management
Connecticut
$463K -$586K -50,423 -62%
Barclays
93
Barclays
United Kingdom
$459K +$222K +19,080 +170%
T. Rowe Price Associates
94
T. Rowe Price Associates
Maryland
$428K +$146K +12,519 +80%
VF
95
Virtu Financial
New York
$380K +$292K +25,101 New
MIM
96
MetLife Investment Management
New Jersey
$367K +$53.4K +4,591 +23%
Allianz Asset Management
97
Allianz Asset Management
Germany
$365K -$1.69M -145,275 -86%
Verition Fund Management
98
Verition Fund Management
Connecticut
$352K +$271K +23,275 New
Principal Financial Group
99
Principal Financial Group
Iowa
$344K -$213K -18,321 -45%
AIG
100
American International Group
New York
$342K +$7.57K +651 +3%
2 3
4
5 6

AERI Hedge Fund Activity: Q3 2022 in Review

156 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2022, worth a combined $703M — up 99% from $354M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new AERI positions and 33 closed out — a net gain of 19 holders — while 47 added to existing stakes and 45 trimmed.

The largest buyer was Water Island Capital, opening a new position worth an estimated $24.2M. The largest seller was Bank of America, cutting an estimated $17.7M.

  • 156 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2022, up from 137 in Q2 2022.
  • Funds reported $703M of Aerie Pharmaceuticals stock for Q3 2022, up 99% quarter-over-quarter.
  • 52 funds opened new Aerie Pharmaceuticals positions in Q3 2022 and 33 closed out, a net change of +19 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2022 was Water Island Capital, an estimated $24.2M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2022 was Bank of America, an estimated $17.7M sold.

Based on aggregated 13F filings for Q3 2022.